SanBio Co Ltd SNBIF
Trading Information
- Previous Close Price
- $14.28
- Day Range
- $10.11–10.11
- 52-Week Range
- $10.11–23.00
- Bid/Ask
- $3.60 / $506.23
- Shares Outstanding
- 78.04M
- Market Cap
- $728.07M
- Volume/Avg
- 45,526 / 17,226
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 33
- Website
- https://www.sanbio.com
Valuation
|
Metric
|
SNBIF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 136.65 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SNBIF
|
|---|---|
Quick Ratio | 28.23 |
Current Ratio | 28.99 |
Interest Coverage | −120.01 |
Quick Ratio
SNBIF
Profitability
|
Metric
|
SNBIF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SNBIF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|xkNN!p# | LOCK|sR$m | $134B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|nBr&<Q | LOCK|!$vs | $83B | |||
| argenx SE ADR
ARGX
| LOCK|$<!<Pg | LOCK|&&b | $63B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|FMp@bBg# | LOCK|$>Pb | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|dHrNd< | LOCK|>? | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|BhxJ&l | LOCK|L%>? | $31B | |||
| Moderna Inc
MRNA
| LOCK|!Ld&C> | LOCK|%H^ | $25B | |||
| Incyte Corp
INCY
| LOCK|Gj$qQ@G | LOCK|Pf | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|B?M<ky | LOCK|&@@ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|dgWRdz& | LOCK|b? | $16B |
United States